| First Author | Marasco MR | Year | 2018 |
| Journal | Diabetes | Volume | 67 |
| Issue | 8 | Pages | 1576-1588 |
| PubMed ID | 29784660 | Mgi Jnum | J:264036 |
| Mgi Id | MGI:6192429 | Doi | 10.2337/db17-1280 |
| Citation | Marasco MR, et al. (2018) Interleukin-6 Reduces beta-Cell Oxidative Stress by Linking Autophagy With the Antioxidant Response. Diabetes 67(8):1576-1588 |
| abstractText | Production of reactive oxygen species (ROS) is a key instigator of beta-cell dysfunction in diabetes. The pleiotropic cytokine interleukin 6 (IL-6) has previously been linked to beta-cell autophagy but has not been studied in the context of beta-cell antioxidant response. We used a combination of animal models of diabetes and analysis of cultured human islets and rodent beta-cells to study how IL-6 influences antioxidant response. We show that IL-6 couples autophagy to antioxidant response and thereby reduces ROS in beta-cells and human islets. beta-Cell-specific loss of IL-6 signaling in vivo renders mice more susceptible to oxidative damage and cell death through the selective beta-cell toxins streptozotocin and alloxan. IL-6-driven ROS reduction is associated with an increase in the master antioxidant factor NRF2, which rapidly translocates to the mitochondria to decrease mitochondrial activity and stimulate mitophagy. IL-6 also initiates a robust transient decrease in cellular cAMP levels, likely contributing to the stimulation of mitophagy to mitigate ROS. Our findings suggest that coupling autophagy to antioxidant response in beta-cells leads to stress adaptation that can reduce cellular apoptosis. These findings have implications for beta-cell survival under diabetogenic conditions and present novel targets for therapeutic intervention. |
